AngioDynamics
ANGO
144 hedge funds and large institutions have $859M invested in AngioDynamics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 66 reducing their positions, and 20 closing their positions.
56% more capital invested
Capital invested by funds: $549M → $859M (+$309M)
31% more call options, than puts
Call options by funds: $1.11M | Put options by funds: $851K
2.57% more ownership
Funds ownership: 94.21% → 96.79% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 147 → 144 (-3)
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
36% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 66
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$38.6M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$21.7M |
| 3 |
Millennium Management
New York
|
+$13.4M |
| 4 |
BlackRock
New York
|
+$5.97M |
| 5 |
CCM
Cinctive Capital Management
New York
|
+$4.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$29.7M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$8.28M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$7.6M |
| 4 |
Renaissance Technologies
New York
|
-$4.19M |
| 5 |
Morgan Stanley
New York
|
-$4.19M |
ANGO Hedge Fund Activity: Q1 2021 in Review
144 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2021, worth a combined $859M — up 56% from $549M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of ANGO and 18 opened new positions — a net loss of 2 holders — while 66 trimmed existing stakes and 42 added.
The largest buyer was Fidelity Investments, adding an estimated $38.6M. The largest seller was Victory Capital Management, cutting an estimated $29.7M.
- 144 institutional investors held AngioDynamics (ANGO) as of Q1 2021, down from 147 in Q4 2020.
- Funds reported $859M of AngioDynamics stock for Q1 2021, up 56% quarter-over-quarter.
- 18 funds opened new AngioDynamics positions in Q1 2021 and 20 closed out, a net change of -2 holders.
- The largest AngioDynamics buyer in Q1 2021 was Fidelity Investments, an estimated $38.6M added.
- The largest AngioDynamics seller in Q1 2021 was Victory Capital Management, an estimated $29.7M sold.
Based on aggregated 13F filings for Q1 2021.